No abstract available
Keywords:
aromatase inhibitor; breast cancer; endocrine therapy duration; low ER+; tamoxifen.
Publication types
-
Editorial
-
Research Support, N.I.H., Extramural
-
Comment
MeSH terms
-
Antineoplastic Agents, Hormonal / therapeutic use
-
Aromatase Inhibitors / therapeutic use
-
Breast Neoplasms* / drug therapy
-
Duration of Therapy
-
Female
-
Humans
-
Receptors, Estrogen*
-
Tamoxifen / therapeutic use
Substances
-
Antineoplastic Agents, Hormonal
-
Aromatase Inhibitors
-
Receptors, Estrogen
-
Tamoxifen
Associated data
-
ClinicalTrials.gov/NCT00003678
-
ClinicalTrials.gov/NCT02531516